EGRP-Supported Epidemiology Consortia
| Title of Initiative | NIH Contacts | Lead Contacts/Principal Investigators | EGRP-Funded Grant (if appropriate) | Consortia Type | Year EGRP Facilitation and/or Funding Began |
|---|---|---|---|---|---|
| Breast and Prostate Cancer Cohort Consortium (BPC3) | EGRP/NCI: Mukesh Verma, Ph.D. vermam@mail.nih.gov DCEG/NCI: |
Lead Contacts/PIs: David Hunter, Sc.D. Channing Laboratory, Harvard University david.hunter@channing.harvard.edu Elio Riboli, M.D., Sc.M., M.P.H. |
Cohort | 2003 | |
| David Hunter, Sc.D. Channing Laboratory, Harvard University david.hunter@channing.harvard.edu |
Characterizing Genetic Susceptibility to Breast and Prostate Cancer; the BPC3 U01CA098233 |
Cohort | 2003 | ||
| Brian Henderson, M.D. University of Southern California/Norris Comprehensive Cancer Center brian.henderson@keck.usc.edu |
Characterizing Genetic Susceptibility to Breast and Prostate Cancer; the BPC3 U01CA098758 |
Cohort | 2003 | ||
| Elio Riboli, M.D., Sc.M., M.P.H. Imperial College, London e.riboli@imperial.ac.uk |
Characterizing Genetic Susceptibility to Breast and Prostate Cancer; the BPC3 U01CA098216 |
Cohort | 2003 | ||
| Michael Thun, M.D., M.S. American Cancer Society michael.thun@cancer.org |
Characterizing Genetic Susceptibility to Breast and Prostate Cancer; the BPC3 U01CA098710 |
Cohort | 2003 | ||
| NCI Cohorts: | |||||
| Demetrius Albanes, M.D. DCEG |
Alpha-Tocopherol, Beta-Carotene Cancer Prevention (ATBC) Study | Cohort | Not Applicable | ||
| Christine Berg, M.D. bergc@mail.nih.gov |
Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial | Cohort | Not Applicable | ||
International
Consortium on Prostate Cancer Genetics (ICPCG) |
EGRP/NCI: Daniela Seminara, Ph.D., M.P.H. seminard@mail.nih.gov NHGRI: Elaine Ostrander, Ph.D. |
Includes various EGRP-funded investigators teamed with NHGRI investigators.
One contact: William Isaacs, Ph.D. Johns Hopkins University wisaacs@jhmi.edu |
Prostate Cancer Susceptibility: The ICPCG Study U01CA089600 |
Familial, Case-control | 2002 |
| Men of African Descent and Prostate Cancer (MADCaP) | EGRP/NCI: Elizabeth Gillanders, Ph.D. lgilland@mail.nih.gov DCEG/NCI |
Lead Contact/PI: Timothy Rebbeck, Ph.D. University of Pennsylvania rebbeck@mail.med.upenn.edu |
Cohort, Case-Control, Familial | ||
| Prostate Cancer
Genetics Study (CaP Genes) |
EGRP/NCI: Daniela Seminara, Ph.D., M.P.H. seminard@mail.nih.gov |
Includes various EGRP-funded investigators. One contact: John Witte, Ph.D. University of California at San Francisco wittej@humgen.ucsf.edu |
Case-control | ||
| Key to Acronyms Used in Tables | |
|---|---|
| EGRP | Epidemiology and Genetics Research Program |
| CDC | Centers for Disease Control and Prevention |
| DCB | Division of Cancer Biology |
| DCEG | Division of Cancer Epidemiology and Genetics |
| NCI | National Cancer Institute |
| NHGRI | National Human Genome Research Institute |
| NIEHS | National Institute of Environmental Health Sciences |
| NIH | National Institutes of Health |
| OCS | Office of Cancer Survivorship |
| OD | Office of the Director |
